THIAGO ALBERTO: Open Payments
NPI 1023650512 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 75 payments from 15 companies in 2025. Trend: 2023 $368 · 2024 $1,442 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $240 |
| Vanda Pharmaceuticals Inc. | 13 | $194 |
| Alkermes, Inc. | 6 | $164 |
| Biogen, Inc. | 4 | $151 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 1 | $35 |
| Corium, LLC | 4 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: VRAYLAR, FANAPT, ZURZUVAE, ARISTADA, COBENFY, REXULTI, CAPLYTA, Qelbree.
Industry payments across ID — which companies pay providers there.
